- Identification of Prognostic Signature and Gliclazide as Candidate Drugs in Lung Adenocarcinoma
Yang Cheng et al, 2021, Frontiers in Oncology CrossRef - SPP1, a potential therapeutic target and biomarker for lung cancer: functional insights through computational studies
Yamuna Annadurai et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef - Pathophysiological Role of Histamine H4 Receptor in Cancer: Therapeutic Implications
Melisa B. Nicoud et al, 2019, Frontiers in Pharmacology CrossRef - Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Rohan Gupta et al, 2021, Molecular Diversity CrossRef - In silico modeling and molecular docking insights of kaempferitrin for colon cancer-related molecular targets
Mydhili Govindarasu et al, 2021, Journal of Saudi Chemical Society CrossRef - Drug Repositioning Identifies Six Drug Candidates for Systemic Autoimmune Diseases by Integrative Analyses of Transcriptomes from Scleroderma, Systemic Lupus Erythematosus, and Sjogren's Syndrome
Elif Kubat Oktem et al, 2022, OMICS: A Journal of Integrative Biology CrossRef - Travma Sonrası Stres Bozukluğu (TSSB) Tedavisine Yönelik Moleküler Hedefler ve Yeniden Konumlandırılan İlaçlar
Elıf KUBAT OKTEM, 2023, Afyon Kocatepe University Journal of Sciences and Engineering CrossRef - Construction of a circRNA-miRNA-mRNA Regulatory Network Reveals Potential Mechanism and Treatment Options for Osteosarcoma
Yi He et al, 2021, Frontiers in Genetics CrossRef - Identification of Novel Drug Candidate for Epithelial Ovarian Cancer via In Silico Investigation and In Vitro Validation
Dan Zou et al, 2021, Frontiers in Oncology CrossRef - Novel Drug Candidate Prediction for Intrahepatic Cholangiocarcinoma via Hub Gene Network Analysis and Connectivity Mapping
Yao Xiao et al, 2022, Cancers CrossRef